Anthony Roth - Embecta Corp Chief VP
| EMBC Stock | USD 10.06 0.23 2.24% |
VP
Anthony Roth is Chief VP of Embecta Corp
| Age | 53 |
| Address | 300 Kimball Drive, Parsippany, NJ, United States, 07054 |
| Phone | 862 401 0000 |
| Web | https://www.embecta.com |
Anthony Roth Latest Insider Activity
Tracking and analyzing the buying and selling activities of Anthony Roth against Embecta Corp stock is an integral part of due diligence when investing in Embecta Corp. Anthony Roth insider activity provides valuable insight into whether Embecta Corp is net buyers or sellers over its current business cycle. Note, Embecta Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Embecta Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Anthony Roth over three months ago Insider Trading |
Embecta Corp Management Efficiency
The company has return on total asset (ROA) of 0.1814 % which means that it generated a profit of $0.1814 on every $100 spent on assets. This is way below average. Embecta Corp's management efficiency ratios could be used to measure how well Embecta Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.56, whereas Return On Tangible Assets are forecasted to decline to 0.1. At present, Embecta Corp's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 102 M, whereas Total Assets are forecasted to decline to about 1.1 B.Similar Executives
| Found 9 records | VP Age | ||
| Dennis Hruby | SIGA Technologies | 74 | |
| GS Jha | CareDx Inc | N/A | |
| Antonio MD | Vir Biotechnology | N/A | |
| Vanina JD | Vir Biotechnology | 47 | |
| Pr MD | Vir Biotechnology | N/A | |
| Brent Sabatini | Vir Biotechnology | 52 | |
| Kurt JD | Maravai Lifesciences Holdings | 45 | |
| Kurt Oreshack | Maravai Lifesciences Holdings | 43 | |
| Jay MD | SIGA Technologies | 52 | |
Management Performance
| Return On Asset | 0.18 |
Embecta Corp Leadership Team
Elected by the shareholders, the Embecta Corp's board of directors comprises two types of representatives: Embecta Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Embecta. The board's role is to monitor Embecta Corp's management team and ensure that shareholders' interests are well served. Embecta Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Embecta Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shaun Curtis, Senior Chain | ||
| Ginny Blocki, Senior Management | ||
| Ajay Kumar, VP Officer | ||
| Pravesh Khandelwal, VP Relations | ||
| Anthony Roth, Chief VP | ||
| Jeffrey Mann, General VP | ||
| Jean Casner, Senior Officer | ||
| Brian Capone, Chief VP | ||
| Slobodan Radumilo, Senior International | ||
| Devdatt Kurdikar, CEO President | ||
| Tom Blount, Senior America | ||
| Colleen Riley, Senior Officer | ||
| Jacob Elguicze, Senior CFO |
Embecta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Embecta Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 1.8 B | ||||
| Shares Outstanding | 59.22 M | ||||
| Shares Owned By Insiders | 1.46 % | ||||
| Shares Owned By Institutions | 98.54 % | ||||
| Number Of Shares Shorted | 3.87 M | ||||
| Price To Earning | 4.91 X | ||||
| Price To Book | 2.61 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 2.36 | Revenue Per Share | Quarterly Revenue Growth (0) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.